Article
Consequences of genetic polymorphisms for sirolimus requirements after renal transplant in patients on primary sirolimus therapy.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons - 1 Mar 2005
Anglicheau Dany, Le Corre Delphine, Lechaton Sophie, Laurent-Puig Pierre, Kreis Henri, Beaune Philippe, Legendre Christophe, Thervet Eric
Abstract excerpt
Sirolimus (SRL) is a substrate for cytochromes P-450 3A and P-glycoprotein, the product of the MDR1 gene. We postulated that single nucleotide polymorphisms (SNPs) of these genes could be associated with inter-individual variations in SRL requirements. We then evaluated in 149 renal transplant recipients the effect of polymorphisms CYP3A4*1/*1B, CYP3A5*1/*3 and MDR1 SNPs in exon 12, 21 and 26 on SRL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
